Antoine Francis: Building the Future of Plasma Supply with Quality, Traceability, and Purpose
Antoine Francis shared a post from Global Plasma Supply on LinkedIn:
“At Global Plasma Supply, we don’t just operate—we stand.
On three pillars engraved into every decision we make:
Quality. Traceability. Purpose.
These aren’t taglines. They are non-negotiables.
They are the foundation for how we collect, protect, and transform plasma into life-saving therapies—ethically and globally.
From donor to vial, from first touch to final dose, our systems ensure:
- Nothing is lost.
- No life is compromised.
- Every drop fulfills its calling.
In a world where regulatory shadows still linger and untraceable plasma slips into questionable circuits, we don’t flinch.
We draw the line.
Only trusted, traceable, purpose-bound plasma has a place in the future of healthcare.
And at GPS—we build that future, drop by drop.”
Read the full article here:
Stay informed on the emerging news in Hematology with Hemostasis Today.
-
Apr 18, 2026, 10:49Advancing Diagnosis to Improve Lives in Hemophilia – WFH
-
Apr 18, 2026, 10:40Akshat Jain: Improving Treatment and Access for Patients with Bleeding Disorders
-
Apr 18, 2026, 10:24Sonia Wolf: Barts Health Presence at BSH with Multiple Presentations and Awards
-
Apr 18, 2026, 10:22Cathy Harrison: The Central Role of Diagnosis in Bleeding Disorders Management
-
Apr 18, 2026, 10:10Rich Gorman: Understanding Lived Experience in Bleeding Disorders Through Arts-Based Research
-
Apr 18, 2026, 09:45Wolfgang Miesbach: Therapeutic Potential of Protein S Inhibition in Glanzmann Thrombasthenia
-
Apr 18, 2026, 00:44Join leading experts for an evening symposium at the ASPHO Conference – ISTH
-
Apr 17, 2026, 17:41José Antonio García Erce: Hematology in 48 Hours – Advancing Clinical Practice Through Expert Insight
-
Apr 17, 2026, 17:23Alfonso J. Tafur: Endovascular Therapy Improves Post-Thrombotic Syndrome Outcomes at 6 Months